Experimental group:Camrelizumab
Sponsors
Department of Oncology, the First Affiliated Hospital of Xi'an jiaotong University, Shandong Institute of Cancer Prevention and Control, Shijiazhuang Ping'an Hospital, The First Affiliated Hospital of Guangxi Medical University, The First Affiliated Hospital of Zhengzhou University
Conditions
Advanced solid tumorCervical carcinomaGastric CarcinomaHepatocellular CarcinomaMalignant solid tumorNeuroendocrine tumorsNon-small cell lung canceran unresectable locally advanced esophageal squamous cell carcinoma
Early Phase 1
A controlled, open-label clinical study for the efficacy and safety of Camrelizumab combined with concurrent Chemoradiotherapy for stage IIIb-IVa cervical cancer
RecruitingChiCTR2000032912
Start: 2020-05-16Updated: 2020-05-18
A study on the efficacy and safety of transcather arterial infusion chemotherapy combined with camrelizumab followed embolization in the treatment of HCC
RecruitingChiCTR2000033353
Start: 2020-06-01Updated: 2020-06-01
A study on the efficacy and safety of transradial access targeting hepatic artery continuous infusion of anticancer drugs followed sequential embolization of primary hepatocellular carcinoma
RecruitingChiCTR2100053256
Start: 2021-12-01Updated: 2022-10-17
Phase 2
Study on the efficacy and safety of Camrelizumab combined with apatinib mesylate in the treatment of patients with advanced neuroendocrine tumors: single arm, phase II trial
RecruitingChiCTR2100041864
Start: 2021-01-30Updated: 2021-03-30
A Single-Arm, Single-Center, Phase II Study Evaluating the Efficacy and Safety of Camrelizumab in the Adjuvant Treatment of MSI-H Locally Advanced Gastric Carcinoma
RecruitingChiCTR2100050575
Start: 2021-09-01Updated: 2022-05-02
Phase 4
Multicenter observational clinical study of Camrelizumab in the treatment of malignant solid tumors
RecruitingChiCTR2000031938
Start: 2020-04-01Updated: 2020-04-27
Prospective, multicenter, observational clinical study of carilizumab in the treatment of advanced solid tumors
RecruitingChiCTR2000038489
Start: 2020-11-01Updated: 2021-01-05
Single Arm Clinical Study on Camrelizumab combined with chemoradiotherapy for the treatment of inoperable locally advanced esophageal squamous cell carcinoma
RecruitingChiCTR2100043004
Start: 2021-03-01Updated: 2021-04-12
An exploratory study based on blood biomarkers predicting complete pathological response after carrelizumab combined with neoadjuvant chemotherapy
Active, not recruitingChiCTR2100047778
Start: 2021-06-22Updated: 2022-02-28